Renamed to AlerisLife Inc in April 2022
FVE - Five Star Senior Living Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Newton,
United States
Type: Equity
FVE price evolution
FVE
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $104.94 | $124.21 | $134.39 | $109.6 |
| Short term investments | $19.5 | $19.44 | $19.53 | $19.96 |
| Net receivables | $8.65 | $9.04 | $9.56 | $9.1 |
| Inventory | ||||
| Total current assets | $185.15 | $252.54 | $270.87 | $262.31 |
| Long term investments | $3.85 | $3.96 | $4.96 | $4.8 |
| Property, plant & equipment | $170.18 | $187.84 | $189.92 | $181.77 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $185.29 | $199.13 | $200.26 | $191.9 |
| Total investments | $23.35 | $23.4 | $24.48 | $24.76 |
| Total assets | $370.44 | $451.68 | $471.13 | $454.21 |
| Current liabilities | ||||
| Accounts payable | $19.85 | $26.47 | $28.26 | $30.04 |
| Deferred revenue | ||||
| Short long term debt | $1.68 | $3.44 | $3.45 | $3.76 |
| Total current liabilities | $122.37 | $174.1 | $179.07 | $177.91 |
| Long term debt | $19.3 | $35.91 | $36.86 | $27.81 |
| Total noncurrent liabilities | $56.3 | $75.6 | $78.44 | $65.77 |
| Total debt | $20.98 | $39.35 | $40.31 | $31.57 |
| Total liabilities | $178.67 | $249.7 | $257.5 | $243.67 |
| Shareholders' equity | ||||
| Retained earnings | -$270.33 | -$260.13 | -$247.82 | -$251.14 |
| Other shareholder equity | $0.98 | $1.05 | $1.02 | $1.32 |
| Total shareholder equity | $191.77 | $201.97 | $213.63 | $210.53 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $109.6 | $56.98 | $50.16 | $48.48 |
| Short term investments | $19.96 | $21.07 | $20.18 | $22.52 |
| Net receivables | $9.1 | $39.72 | $45.61 | $43.45 |
| Inventory | ||||
| Total current assets | $262.31 | $143.37 | $138.05 | $197.19 |
| Long term investments | $4.8 | $7.4 | $16.71 | $18.94 |
| Property, plant & equipment | $181.77 | $188.1 | $243.87 | $251.5 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $191.9 | $202.43 | $267.57 | $278.72 |
| Total investments | $24.76 | $28.47 | $36.88 | $41.47 |
| Total assets | $454.21 | $345.79 | $405.62 | $475.91 |
| Current liabilities | ||||
| Accounts payable | $30.04 | $84.69 | $88.55 | $93.42 |
| Deferred revenue | ||||
| Short long term debt | $3.76 | $3.23 | $51.82 | $0.32 |
| Total current liabilities | $177.91 | $164.3 | $229.69 | $218.64 |
| Long term debt | $27.81 | $26.84 | $7.53 | $7.87 |
| Total noncurrent liabilities | $65.77 | $61.51 | $104.76 | $112.27 |
| Total debt | $31.57 | $30.08 | $59.36 | $8.19 |
| Total liabilities | $243.67 | $225.81 | $334.45 | $330.91 |
| Shareholders' equity | ||||
| Retained earnings | -$251.14 | -$245.18 | -$292.64 | -$220.49 |
| Other shareholder equity | $1.32 | $2.66 | $1.74 | $4.04 |
| Total shareholder equity | $210.53 | $119.98 | $71.17 | $144.99 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $225.83 | $258.62 | $269.1 | $285.89 |
| Cost of revenue | $206.5 | $229.8 | $247.65 | $260.53 |
| Gross Profit | $19.33 | $28.82 | $21.45 | $25.36 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $21.82 | $22.75 | $22.64 | $20.82 |
| Total operating expenses | $26.02 | $41.12 | $17.79 | $23.08 |
| Operating income | -$6.69 | -$12.31 | $3.66 | $2.28 |
| Income from continuing operations | ||||
| EBIT | -$9.86 | -$11.73 | $3.98 | $3.06 |
| Income tax expense | -$0.16 | $0.16 | $0.2 | -$0.31 |
| Interest expense | $0.51 | $0.41 | $0.46 | $0.46 |
| Net income | ||||
| Net income | -$10.2 | -$12.3 | $3.31 | $2.9 |
| Income (for common shares) | -$10.2 | -$12.3 | $3.31 | $2.9 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1163.74 | $1415.14 | $1390.39 | $1396.11 |
| Cost of revenue | $1047.95 | $1185.27 | $1145.35 | $1104.37 |
| Gross Profit | $115.79 | $229.87 | $245.05 | $291.74 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $87.17 | $87.88 | $78.19 | $75.21 |
| Total operating expenses | $99.85 | $250.15 | $316.61 | $314.79 |
| Operating income | $15.94 | -$20.27 | -$71.56 | -$23.05 |
| Income from continuing operations | ||||
| EBIT | -$5.29 | -$17.32 | -$70.82 | -$21.13 |
| Income tax expense | $0.66 | $0.06 | $0.25 | -$4.54 |
| Interest expense | $1.63 | $2.62 | $3.02 | $4.31 |
| Net income | ||||
| Net income | -$7.59 | -$20 | -$74.08 | -$20.9 |
| Income (for common shares) | -$7.59 | -$20 | -$74.08 | -$20.9 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$10.2 | -$12.3 | $3.31 | $2.9 |
| Operating activities | ||||
| Depreciation | $2.98 | $2.99 | $2.94 | $2.91 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.06 | $0.63 | $0.07 | $0.19 |
| Total cash flows from operations | -$16.08 | -$8.95 | $26.83 | -$10.66 |
| Investing activities | ||||
| Capital expenditures | -$2.88 | -$2.33 | -$2.14 | -$1.29 |
| Investments | $1.6 | $0.21 | $1.27 | |
| Total cash flows from investing | -$2.88 | -$0.73 | -$1.93 | -$0.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$0.31 | -$0.5 | -$0.1 | -$0.1 |
| Total cash flows from financing | -$0.31 | -$0.5 | -$0.1 | -$0.16 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $85.67 | -$10.18 | $24.79 | -$10.85 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Net income | -$7.59 | -$20 | -$74.08 | -$20.9 |
| Operating activities | ||||
| Depreciation | $11 | $16.64 | $35.94 | $38.19 |
| Business acquisitions & disposals | $0.29 | $8.25 | $31.82 | $39.08 |
| Stock-based compensation | $0.51 | $0.44 | $0.62 | $1.09 |
| Total cash flows from operations | $51.38 | -$4.11 | -$54.22 | $16.12 |
| Investing activities | ||||
| Capital expenditures | -$2.7 | $52.53 | -$31.02 | -$30.55 |
| Investments | $4.66 | $2.2 | $4.14 | $2.72 |
| Total cash flows from investing | $2.24 | $62.98 | $4.94 | $11.25 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.56 | |||
| Net borrowings | -$0.39 | -$51.85 | $50.98 | -$16.77 |
| Total cash flows from financing | -$1.01 | -$53.15 | $50.96 | -$18.72 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $52.62 | $5.73 | $1.68 | $9.65 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 31.75M |
| Revenue | $1.04B |
|---|---|
| EBITDA | -$2.73M |
| EBIT | -$14.56M |
| Net Income | -$16.29M |
| Revenue Q/Q | -23.53% |
| Revenue Y/Y | -15.37% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 6.01 |
| Cash/Share | 3.31 |
| EPS | -$0.51 |
|---|---|
| ROA | -3.73% |
| ROE | -7.96% |
| Debt/Equity | 1.16 |
|---|---|
| Net debt/EBITDA | -26.97 |
| Current ratio | 1.51 |
| Quick ratio | 1.51 |